iStar Inc (STAR) Jumps 6.02% on January 26

Equities Staff |

iStar Inc (STAR) was among the biggest gainers on the Russell 2000 for Tuesday January 26 as the stock popped 6.02% to $10.04, representing a gain of $0.57 per share. Some 867,320 shares traded hands on 4,217 trades, compared with an average daily volume of 988,235 shares out of a total float of 84.8 million. The stock opened at $9.54 and traded with an intraday range of $10.05 to $9.48.

After today's gains, iStar Inc reached a market cap of $851.44 million. iStar Inc has had a trading range between $14.77 and $8.96 over the last year, and it had a 50-day SMA of $11.81 and a 200-day SMA of $12.91.

iStar Inc is structured as a real estate investment trust. The Company finances, invests in and develops real estate and real estate related projects as part of its fully-integrated investment platform.

iStar Inc is based out of New York, NY and has some 182 employees. Its CEO is Jay Sugarman.

For a complete fundamental analysis analysis of iStar Inc, check out Equities.com’s Stock Valuation Analysis report for STAR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…